These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

436 related items for PubMed ID: 14567723

  • 1. Differential amplification and overexpression of HER-2/neu, p53, MIB1, and estrogen receptor/progesterone receptor among medullary carcinoma, atypical medullary carcinoma, and high-grade invasive ductal carcinoma of breast.
    Xu R, Feiner H, Li P, Yee H, Inghirami G, Delgado Y, Perle MA.
    Arch Pathol Lab Med; 2003 Nov; 127(11):1458-64. PubMed ID: 14567723
    [Abstract] [Full Text] [Related]

  • 2. Mitochondrial DNA alterations correlate with the pathological status and the immunological ER, PR, HER-2/neu, p53 and Ki-67 expression in breast invasive ductal carcinoma.
    Lin CS, Chang SC, Ou LH, Chen CM, Hsieh SS, Chung YP, King KL, Lin SL, Wei YH.
    Oncol Rep; 2015 Jun; 33(6):2924-34. PubMed ID: 25845386
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Study of ER, PR, HER2/neu, p53, and Ki67 expression in primary breast carcinomas and synchronous metastatic axillary lymph nodes.
    Khande TA, Joshi AR, Khandeparkar SGS, Kulkarni MM, Gogate BP, Kakade AR, Sahu PD, Khillare CD.
    Indian J Cancer; 2020 Jun; 57(2):190-197. PubMed ID: 32445323
    [Abstract] [Full Text] [Related]

  • 5. Correlation of hormone receptors with Her-2 Neu protein expression and the histological grade in invasive breast cancers in a cohort of Saudi Arabia.
    Arafah M.
    Turk Patoloji Derg; 2012 Jun; 28(1):38-43. PubMed ID: 22207430
    [Abstract] [Full Text] [Related]

  • 6. Correlation of her-2/neu gene amplification with other prognostic and predictive factors in female breast carcinoma.
    Ariga R, Zarif A, Korasick J, Reddy V, Siziopikou K, Gattuso P.
    Breast J; 2005 Jun; 11(4):278-80. PubMed ID: 15982396
    [Abstract] [Full Text] [Related]

  • 7. The Immunophenotype of Nodular Variant of Medullary Carcinoma of the Breast.
    Reyes C, Nadji M.
    Appl Immunohistochem Mol Morphol; 2015 Oct; 23(9):624-7. PubMed ID: 25710588
    [Abstract] [Full Text] [Related]

  • 8. Prognostic significance of p34cdc2 cyclin-dependent kinase and MIB1 overexpression, and HER-2/neu gene amplification detected by fluorescence in situ hybridization in breast cancer.
    Depowski PL, Brien TP, Sheehan CE, Stylos S, Johnson RL, Ross JS.
    Am J Clin Pathol; 1999 Oct; 112(4):459-69. PubMed ID: 10510669
    [Abstract] [Full Text] [Related]

  • 9. Interrelationships Between Ki67, HER2/neu, p53, ER, and PR Status and Their Associations With Tumor Grade and Lymph Node Involvement in Breast Carcinoma Subtypes: Retrospective-Observational Analytical Study.
    Shokouh TZ, Ezatollah A, Barand P.
    Medicine (Baltimore); 2015 Aug; 94(32):e1359. PubMed ID: 26266392
    [Abstract] [Full Text] [Related]

  • 10. Assessment of Her-2/neu gene amplification status in breast carcinoma with equivocal 2+ Her-2/neu immunostaining.
    Mostafa NA, Eissa SS, Belal DM, Shoman SH.
    J Egypt Natl Canc Inst; 2011 Mar; 23(1):41-6. PubMed ID: 22099935
    [Abstract] [Full Text] [Related]

  • 11. Correlations among p53, Her-2/neu, and ras overexpression and aneuploidy by multiparameter flow cytometry in human breast cancer: evidence for a common phenotypic evolutionary pattern in infiltrating ductal carcinomas.
    Smith CA, Pollice AA, Gu LP, Brown KA, Singh SG, Janocko LE, Johnson R, Julian T, Hyams D, Wolmark N, Sweeney L, Silverman JF, Shackney SE.
    Clin Cancer Res; 2000 Jan; 6(1):112-26. PubMed ID: 10656439
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer.
    Konecny G, Pauletti G, Pegram M, Untch M, Dandekar S, Aguilar Z, Wilson C, Rong HM, Bauerfeind I, Felber M, Wang HJ, Beryt M, Seshadri R, Hepp H, Slamon DJ.
    J Natl Cancer Inst; 2003 Jan 15; 95(2):142-53. PubMed ID: 12529347
    [Abstract] [Full Text] [Related]

  • 20. Simultaneous bilateral breast carcinomas: a category with frequent coexpression of HER-2 and ER-alpha, high Ki-67 and bcl-2, and low p53.
    Bassarova AV, Nesland JM, Sedloev T, Lilleby W, Hristova SL, Trifonov DY, Torlakovic E.
    Int J Surg Pathol; 2005 Jul 15; 13(3):239-46. PubMed ID: 16086078
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.